Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Name: Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anti-hiv-agents combination drug-therapy genotype hiv-1 hiv-infections rna viral

hiv infections, hiv-1, didanosine, drug therapy, combination, drug administration schedule, cd4-positive t-lymphocytes, hydroxyurea, rna, viral, genotype, reverse transcriptase inhibitors, anti-hiv agents, viral load

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 836882
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.